NCT06389552View on ClinicalTrials.gov

Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Adjuvant Chemotherapy
Trial Locations (1)

Unknown

RECRUITING

Seoul ST. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT06389552 - Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients | Biotech Hunter | Biotech Hunter